Serum levels of MMP-7 in primary brain cancers and brain metastases

References

• Lai JS, Jensen SE, Beaumont JL. Development of a symptom index for patients with primary brain tumors. Value Health. 2014;17:62–69.
   PubMed Web of Science ®Google Scholar
• Swartling FJ, Hede SM, Weiss WA. What underlies the diversity of brain tumors? Cancer Metastasis Rev. 2013;32:5–24.
   PubMed Web of Science ®Google Scholar
• Kahn K, Finkel A. It IS a tumor – current review of headache and brain tumor. Curr Pain Headache Rep. 2014;18:421.
   PubMed Web of Science ®Google Scholar
• Gregg N, Arber A, Ashkan K, et al. Neurobehavioural changes in patients following brain tumour: patients and relatives perspective. Support Care Cancer. 2014;22:2965–2972.
   PubMed Web of Science ®Google Scholar
• Richter A, Woernle CM, Krayenbuhl N, et al. Affective symptoms and white matter changes in brain tumor patients. World Neurosurg. 2015;84:927–932.
   PubMed Web of Science ®Google Scholar
• Cahill J, LoBiondo-Wood G, Bergstrom N, et al. Brain tumor symptoms as antecedents to uncertainty: an integrative review. J Nurs Scholarsh. 2012;44:145–155.
   PubMed Web of Science ®Google Scholar
• Zhao L, Jia K. Multiscale CNNs for brain tumor segmentation and diagnosis. Comput Math Methods Med. 2016; 8356294. doi:10.1155/2016/8356294. Epub 2016 March 16.
   Web of Science ®Google Scholar
• Shiroishi MS, Castellazzi G, Boxerman JL, et al. Principles of T2-weighted dynamic susceptibility contrast MRI technique in brain tumor imaging. J Magn Reson Imaging. 2015;41:296–313.
   PubMed Web of Science ®Google Scholar
• Gates M, Alsaidi M, Kalkanis S. Surgical treatment of solitary brain metastases. Prog Neurol Surg. 2012;25:74–81.
   PubMedGoogle Scholar
• Zanders ED, Svensson F, Bailey DS. Therapy for glioblastoma: is it working? Drug Discov Today. 2019;24:1193–1201.
   PubMed Web of Science ®Google Scholar
• Fidler IJ. The biology of brain metastasis: challenges for therapy. Cancer J. 2015;21:284–293.
   PubMed Web of Science ®Google Scholar
• Konnecke H, Bechmann I. The role of microglia and matrix metalloproteinases involvement in neuroinflammation and gliomas. Clin Dev Immunol. 2013;2013:914104.
   PubMedGoogle Scholar
• Szklarczyk A, Oyler G, McKay R, et al. Cleavage of neuronal synaptosomal-associated protein of 25 kDa by exogenous matrix metalloproteinase-7. J Neurochem. 2007;102:1256–1263.
   PubMed Web of Science ®Google Scholar
• Apte SS, Parks WC. Metalloproteinases: a parade of functions in matrix biology and an outlook for the future. Matrix Biol. 2015;46:1–6.
   Web of Science ®Google Scholar
• Kapoor C, Vaidya S, Wadhwan V, et al. Seesaw of matrix metalloproteinases (MMPs). J Cancer Res Ther. 2016;12:28–35.
   PubMed Web of Science ®Google Scholar
• Wyganowska-Świątkowska M, Tarnowski M, Murtagh D, et al. Proteolysis is the most fundamental property of malignancy and its inhibition may be used therapeutically (Review). Int J Mol Med. 2019;43:15–25.
   PubMed Web of Science ®Google Scholar
• Tacheva T, Dimov D, Anastasov A, et al. Association of the MMP7 -181A > G promoter polymorphism with early onset of chronic obstructive pulmonary disease. Balkan J Med Genet. 2017;20:59–66.
   Web of Science ®Google Scholar
• Ke B, Fan C, Yang L, et al. Matrix metalloproteinases-7 and kidney fibrosis. Front Physiol. 2017;8:21.
   PubMed Web of Science ®Google Scholar
• Han JC, Li XD, Du J, et al. Elevated matrix metalloproteinase-7 expression promotes metastasis in human lung carcinoma. World J Surg Oncol. 2015;13:5.
   PubMed Web of Science ®Google Scholar
• Anastasov A, Vihinen P, Nikkola J, et al. Matrix metalloproteinases in development and progression of skin malignant melanoma. Sci Technol Med. 2011;1:234–241.
   Google Scholar
• Guilfoyle MR, Carpenter KL, Helmy A, et al. Matrix metalloproteinase expression in contusional traumatic brain injury: a paired microdialysis study. J Neurotrauma. 2015;32:1553–1559.
   PubMed Web of Science ®Google Scholar
• Mu N, Gu J, Liu N, et al. PRL-3 is a potential glioblastoma prognostic marker and promotes glioblastoma progression by enhancing MMP7 through the ERK and JNK pathways. Theranostics. 2018;8:1527–1539.
   PubMed Web of Science ®Google Scholar
• Xie H, Xue YX, Liu LB, et al. Expressions of matrix metalloproteinase-7 and matrix metalloproteinase-14 associated with the activation of extracellular signal-regulated kinase1/2 in human brain gliomas of different pathological grades. Med Oncol. 2011;28:433–438.
   Web of Science ®Google Scholar
• Frye MA, Nassan M, Jenkins GD, et al. Feasibility of investigating differential proteomic expression in depression: implications for biomarker development in mood disorders. Transl Psychiat. 2015; December 8;5:e689. doi:10.1038/tp.2015.185.
   Web of Science ®Google Scholar
• Szklarczyk A, Ewaleifoh O, Beique JC, et al. MMP-7 cleaves the NR1 NMDA receptor subunit and modifies NMDA receptor function. FASEB J. 2008;22:3757–3767.
   PubMed Web of Science ®Google Scholar
• Buhler LA, Samara R, Guzman E, et al. Matrix metalloproteinase-7 facilitates immune access to the CNS in experimental autoimmune encephalomyelitis. BMC Neurosci. 2009;10:1471–2202.
   Web of Science ®Google Scholar
• Tominaga N, Kosaka N, Ono M, et al. Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood-brain barrier. Nat Commun. 2015;6:6716.
   PubMed Web of Science ®Google Scholar
• Ragin AB, Wu Y, Ochs R, et al. Serum matrix metalloproteinase levels correlate with brain injury in human immunodeficiency virus infection. J Neurovirol. 2009;15:275–281.
   PubMed Web of Science ®Google Scholar
• Gaide Chevronnay HP, Selvais C, Emonard H, et al. Regulation of matrix metalloproteinases activity studied in human endometrium as a paradigm of cyclic tissue breakdown and regeneration. Biochim Biophys Acta. 2012;2012:146–156.
   Web of Science ®Google Scholar
• McGuire JK, Li Q, Parks WC. Matrilysin (matrix metalloproteinase-7) mediates E-cadherin ectodomain shedding in injured lung epithelium. Am J Pathol. 2003;162:1831–1843.
   PubMed Web of Science ®Google Scholar
• Sizemore ST, Sizemore GM, Booth CN, et al. Hypomethylation of the MMP7 promoter and increased expression of MMP7 distinguishes the basal-like breast cancer subtype from other triple-negative tumors. Breast Cancer Res Treat. 2014;146:25–40.
   PubMed Web of Science ®Google Scholar
• Yokoyama Y, Grunebach F, Schmidt SM, et al. Matrilysin (MMP-7) is a novel broadly expressed tumor antigen recognized by antigen-specific T cells. Clin Cancer Res. 2008;14:5503–5511.
   PubMed Web of Science ®Google Scholar
• Raghu H, Nalla AK, Gondi CS, et al. uPA and uPAR shRNA inhibit angiogenesis via enhanced secretion of SVEGFR1 independent of GM-CSF but dependent on TIMP-1 in endothelial and glioblastoma cells. Mol Oncol. 2012;6:33–47.
   PubMed Web of Science ®Google Scholar
• Rome C, Arsaut J, Taris C, et al. MMP-7 (matrilysin) expression in human brain tumors. Mol Carcinog. 2007;46:446–452.
   PubMed Web of Science ®Google Scholar
• Tie X, Han S, Meng L, et al. NFAT1 is highly expressed in, and regulates the invasion of, glioblastoma multiforme cells. PLoS One. 2013;8:e66008.
   PubMed Web of Science ®Google Scholar
• Xu SL, Liu S, Cui W, et al. Aldehyde dehydrogenase 1A1 circumscribes high invasive glioma cells and predicts poor prognosis. Am J Cancer Res. 2015;5:1471–1483.
   PubMed Web of Science ®Google Scholar
• Shi Y, Chen C, Zhang X, et al. Primate-specific miR-663 functions as a tumor suppressor by targeting PIK3CD and predicts the prognosis of human glioblastoma. Clin Cancer Res. 2014;20:1803–1813.
   PubMed Web of Science ®Google Scholar
• Li H, Yu L, Liu J, et al. miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patients. Oncotarget. 2017;8:19723–19737.
   PubMedGoogle Scholar
• Jormsjo S, Whatling C, Walter DH, et al. Allele-specific regulation of matrix metalloproteinase-7 promoter activity is associated with coronary artery luminal dimensions among hypercholesterolemic patients. ATVB. 2001;21:1834–1839.
   Google Scholar
• Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res. 2003;92:827–839.
   PubMed Web of Science ®Google Scholar
• Kouwenhoven M, Ozenci V, Gomes A, et al. Multiple sclerosis: elevated expression of matrix metalloproteinases in blood monocytes. J Autoimmun. 2001;16:463–470.
   PubMed Web of Science ®Google Scholar
• Newby AC. Metalloproteinase production from macrophages – a perfect storm leading to atherosclerotic plaque rupture and myocardial infarction. Exp Physiol. 2016;101:1327–1337.
   PubMed Web of Science ®Google Scholar
• Harter PN, Bernatz S, Scholz A, et al. Distribution and prognostic relevance of tumor-infiltrating lymphocytes (TILs) and PD-1/PD-L1 immune checkpoints in human brain metastases. Oncotarget. 2015;6:40836–40849.
   PubMed Web of Science ®Google Scholar